Nick Law, the global chief creative officer of R/GA, is leaving the company after 17 years to take on the newly created role of chief creative officer across Publicis Groupe and president of Publicis Communications.
Sanofi to buy Bioverativ for $11.6 billion; Celgene to acquire Juno for $9 billion; Teva to lay off more than 200 in Philadelphia
She is overseeing three of the network's agencies in the newly created role.
Sigurdsson is charged with leading the agency's digital offering to meet growing client demand.
Pharma looks to Spark for pricing blueprint; Ipsen hires Amgen exec as CEO of North America; FDA could improve social-media approach, study finds
Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations
Kevin Griffis brought his experience in government and politics to Planned Parenthood at the perfect time, leading the fight to protect birth control coverage under the Trump administration and destigmatizing abortion.
Allergan to cut 1,000 jobs; McKesson acquires RxCrossroads from CVS Health; Pfizer and Sangamo enter collaboration to develop ALS gene therapy
The Department of Veteran Affairs issued an RFI at the end of November for a nationwide healthcare professional recruitment campaign.
The agency issue, people moves, and a series of restructures top the list.
VP of investor relations Teri Loxam will take over Ambrose's role in January.
Beiser previously held leadership roles at Edelman, Hilton, Discover, and Burson-Marsteller.
FDA approves first topical skin growth treatment; Teva to cut 14,000 jobs; Novartis Oncology CEO resigns
Teva diminishes debt with job cuts and sale; FDA to study whether consumers can detect misleading ads; AbbVie, Roche present positive Phase-III data at ASH
The drugmaker named William Huyett as COO and Gina Consylman as SVP and CFO.
GCI Health has confirmed new hire Kath Kerry and maternity leave returner Rikki Jones as co-MDs of its London operation, the network's second hub alongside its New York headquarters.
DeVine will oversee the agency's health IT and medical device work.
Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds
Publicis Groupe has named Alan Wexler as chief executive of Publicis.Sapient as Chip Register has chosen to retire at the end of the year.
Docs biased against research from poor countries, study finds; Astellas probed over patient-assistance charity support; Acorda reports deaths in Parkinson's trial
FDA approves first digital pill; biotech companies race to develop cancer-fighting microbiome drugs; Loxo and Bayer reach $1.55 billion deal for rare cancer drugs
Dynavax receives FDA approval for hepatitis-B vaccine; Novartis strikes R&D deal with gene-editing startup; White House nominates new HHS head
W2O's Windy City office has added three health and analytics leaders over the past six months.
Ty Curran, previously CEO of the sister agencies, will serve as chairman in 2018.
Optum vet Miller replaces Jessica Boden.
Non-profit challenges Gilead's Sovaldi patent; The Medicines Company to cut hundreds of jobs; Amgen ends R&D for experimental CETP drug
This year's offering includes access to the most current and in-depth data on salary and compensation trends, job satisfaction, recruitment and retention tactics, and more.
From IKEA to eye-opening health campaigns, S&S Wellness' CCO helps turn emotion into action.
The association said it is preparing for new FDA approvals for therapies that treat central nervous system and muscular system diseases.
Every agency in the biz claims to have a "unique" culture and one that fuels a great deal of its success.